SUSAN T LAING, M.D.
Osteopathic Medicine at Fannin St, Houston, TX
License number
Texas M5314
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
2
6410 Fannin St, Houston, TX 77030
PO Box 301173, Dallas, TX 75303
PO Box 301173, Dallas, TX 75303
Phone
(832) 325-7211
(713) 500-3500
(713) 500-3500
Personal information
See more information about SUSAN T LAING at radaris.comName
Address
Phone
3029 Blue Bonnet Blvd, Houston, TX 77025
6410 Fannin St, Houston, TX 77030
Professional information
Susan D Laing, Houston TX
Specialties:
Cardiologist
Address:
6431 Fannin St, Houston, TX 77030
6410 Fannin St, Houston, TX 77030
6410 Fannin St, Houston, TX 77030
Education:
University of the Philippines, College of Medicine (Manila) - Doctor of Medicine
Northwestern Memorial Hospital - Fellowship - Cardiology
University of Illinois Medical Center at Chicago - Residency - Internal Medicine
Northwestern Memorial Hospital - Fellowship - Cardiology
University of Illinois Medical Center at Chicago - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine)
Echogenic Vehicle For Clinical Delivery Of Plasminogen Activator And Other Fibrin-Binding Therapeutics To Thrombi
US Patent:
2008030, Dec 11, 2008
Filed:
Mar 7, 2008
Appl. No.:
12/044189
Inventors:
Susan T. Laing - Houston TX, US
Shaoling Huang - Houston TX, US
David D. McPherson - Houston TX, US
Christy K. Holland - Cincinnati OH, US
Melvin E. Klegerman - Houston TX, US
Shaoling Huang - Houston TX, US
David D. McPherson - Houston TX, US
Christy K. Holland - Cincinnati OH, US
Melvin E. Klegerman - Houston TX, US
International Classification:
A61K 9/127, A61P 7/02
US Classification:
424450
Abstract:
We disclose a composition comprising an echogenic liposome (ELIP) having an exterior surface, an interior surface, and at least one bilayer comprising at least one lipid selected from the group consisting of saturated phospholipids, unsaturated phospholipids, mixed phospholipids, and cholesterol, and a thrombolytic compound trapped by the ELIP. We also disclose a method of treating a medical condition in a patient characterized by a thrombus in the patient's vasculature, comprising administering to the patient the composition in an amount effective to reduce the size of the thrombus.